Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2021 Filed Jan 29, 2021 20:01 UTC |
FORMICA FRANK JDirector
|
SaleCommon Stock | 5,000 | $38.59 | $192,950.00 |
DisclosureSEC source: 0001437749-21-001572 · rdgdoc.xml · nonDerivative · entry 1 FORMICA FRANK J · CIK 0001263825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Read SEC document |
| January 28, 2021 Filed Jan 28, 2021 21:57 UTC |
ROSENBLOOM BRUCE SCFO & Treasurer
|
SaleCOMMON STOCK | 5,000 | $50.00 | $250,000.00 |
DisclosureSEC source: 0001437749-21-001506 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,525 Read SEC document |
| January 28, 2021 Filed Jan 29, 2021 17:17 UTC |
FULGONI GIANDirector
|
SaleCOMMON STOCK | 2,890 | $50.93 | $147,187.70 |
DisclosureSEC source: 0001437749-21-001547 · rdgdoc.xml · nonDerivative · entry 2 FULGONI GIAN · CIK 0001254384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,510 Read SEC document |
| January 27, 2021 Filed Jan 28, 2021 21:38 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCOMMON STOCK | 60,000 | $45.50 | $2,730,000.00 |
DisclosureSEC source: 0001437749-21-001502 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,800 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| January 27, 2021 Filed Jan 29, 2021 17:17 UTC |
FULGONI GIANDirector
|
SaleCOMMON STOCK | 10,000 | $46.03 | $460,300.00 |
DisclosureSEC source: 0001437749-21-001547 · rdgdoc.xml · nonDerivative · entry 1 FULGONI GIAN · CIK 0001254384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,400 Read SEC document |
| January 13, 2021 Filed Jan 14, 2021 17:35 UTC |
KORN RONALD JDirector
|
SaleCommon Stock | 2,000 | $35.00 | $70,000.00 |
DisclosureSEC source: 0001437749-21-000706 · rdgdoc.xml · nonDerivative · entry 1 KORN RONALD J · CIK 0001249320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,333 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| December 24, 2020 Filed Dec 28, 2020 20:01 UTC |
KORN RONALD JDirector
|
SaleCommon Stock | 2,000 | $34.00 | $68,000.00 |
DisclosureSEC source: 0001437749-20-025936 · rdgdoc.xml · nonDerivative · entry 1 KORN RONALD J · CIK 0001249320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,333 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| December 18, 2020 Filed Dec 18, 2020 17:31 UTC |
KORN RONALD JDirector
|
SaleCommon Stock | 2,000 | $33.00 | $66,000.00 |
DisclosureSEC source: 0001437749-20-025606 · rdgdoc.xml · nonDerivative · entry 1 KORN RONALD J · CIK 0001249320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,333 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 17:19 UTC |
KORN RONALD JDirector
|
SaleCommon Stock | 2,000 | $32.00 | $64,000.00 |
DisclosureSEC source: 0001437749-20-023959 · rdgdoc.xml · nonDerivative · entry 1 KORN RONALD J · CIK 0001249320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,333 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| August 28, 2020 Filed Aug 31, 2020 17:37 UTC |
SCHWEITZER ROBERT CDirector
|
SaleCommon Stock | 7,500 | $36.28 | $272,100.00 |
DisclosureSEC source: 0001437749-20-018998 · rdgdoc.xml · nonDerivative · entry 1 SCHWEITZER ROBERT C · CIK 0001254385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,834 Read SEC document |
| August 28, 2020 Filed Aug 31, 2020 17:37 UTC |
FORMICA FRANK JDirector
|
SaleCommon Stock | 4,500 | $35.68 | $160,560.00 |
DisclosureSEC source: 0001437749-20-018997 · rdgdoc.xml · nonDerivative · entry 1 FORMICA FRANK J · CIK 0001263825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 15:05 UTC |
ROSENBLOOM BRUCE SChief Financial Officer
|
GrantCommon Stock | 9,775 | $31.20 | $304,980.00 |
DisclosureSEC source: 0001437749-20-016428 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,525 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Rosenbloom retains voting rights over all the shares while in escrow. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 14:50 UTC |
FORMICA FRANK JDirector
|
GrantCommon Stock | 7,500 | $31.20 | $234,000.00 |
DisclosureSEC source: 0001437749-20-016425 · rdgdoc.xml · nonDerivative · entry 1 FORMICA FRANK J · CIK 0001263825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,500 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Formica retains voting rights over all the shares while in escrow. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 14:50 UTC |
FULGONI GIANDirector
|
GrantCommon Stock | 7,500 | $31.20 | $234,000.00 |
DisclosureSEC source: 0001437749-20-016426 · rdgdoc.xml · nonDerivative · entry 1 FULGONI GIAN · CIK 0001254384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,400 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Fulgoni retains voting rights over all the shares while in escrow. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 14:49 UTC |
Campbell Leslie C.G.Director
|
GrantCommon Stock | 7,500 | $31.20 | $234,000.00 |
DisclosureSEC source: 0001437749-20-016424 · rdgdoc.xml · nonDerivative · entry 1 Campbell Leslie C.G. · CIK 0001686078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Ms. Campbell retains voting rights over all the shares while in escrow. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 14:48 UTC |
KORN RONALD JDirector
|
GrantCommon Stock | 7,500 | $31.20 | $234,000.00 |
DisclosureSEC source: 0001437749-20-016421 · rdgdoc.xml · nonDerivative · entry 1 KORN RONALD J · CIK 0001249320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,333 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Korn retains voting rights over all the shares while in escrow. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 14:49 UTC |
AKDAG MENDERESDirector · CEO & President
|
GrantCommon Stock | 37,800 | $31.20 | $1,179,360.00 |
DisclosureSEC source: 0001437749-20-016422 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,800 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released over a one year period condition upon continued employment. Mr. Akdag retains voting rights over all the shares while in escrow. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 14:48 UTC |
SCHWEITZER ROBERT CDirector
|
GrantCommon Stock | 7,500 | $31.20 | $234,000.00 |
DisclosureSEC source: 0001437749-20-016420 · rdgdoc.xml · nonDerivative · entry 1 SCHWEITZER ROBERT C · CIK 0001254385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,334 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Schweitzer retains voting rights over all the shares while in escrow. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 15:56 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 30,000 | $41.00 | $1,230,000.00 |
DisclosureSEC source: 0001437749-20-015389 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 17:24 UTC |
ROSENBLOOM BRUCE SChief Financial Officer
|
SaleCommon Stock | 3,334 | $40.00 | $133,360.00 |
DisclosureSEC source: 0001437749-20-008978 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,550 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| April 27, 2020 Filed Apr 28, 2020 16:13 UTC |
ROSENBLOOM BRUCE SChief Financial Officer
|
SaleCommon Stock | 3,500 | $35.00 | $122,500.00 |
DisclosureSEC source: 0001437749-20-008662 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,884 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 18:12 UTC |
ROSENBLOOM BRUCE SChief Financial Officer
|
SaleCommon Stock | 3,500 | $32.50 | $113,750.00 |
DisclosureSEC source: 0001437749-20-007936 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,384 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| April 07, 2020 Filed Apr 8, 2020 15:04 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 20,000 | $31.25 | $625,000.00 |
DisclosureSEC source: 0001437749-20-007303 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 16:42 UTC |
ROSENBLOOM BRUCE SChief Financial Officer
|
SaleCommon Stock | 3,500 | $30.00 | $105,000.00 |
DisclosureSEC source: 0001437749-20-007253 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,884 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| April 06, 2020 Filed Apr 7, 2020 16:41 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 20,000 | $30.25 | $605,000.00 |
DisclosureSEC source: 0001437749-20-007252 · rdgdoc.xml · nonDerivative · entry 2 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 16:41 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 10,000 | $29.50 | $295,000.00 |
DisclosureSEC source: 0001437749-20-007252 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 20:42 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 10,000 | $29.00 | $290,000.00 |
DisclosureSEC source: 0001437749-20-003355 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| February 19, 2020 Filed Feb 20, 2020 17:20 UTC |
ROSENBLOOM BRUCE SChief Financial Officer
|
SaleCommon Stock | 3,500 | $28.22 | $98,770.00 |
DisclosureSEC source: 0001437749-20-003127 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,384 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 14:54 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 2,381 | $28.00 | $66,668.00 |
DisclosureSEC source: 0001437749-20-002975 · rdgdoc.xml · nonDerivative · entry 2 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 14:54 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 57,619 | $28.11 | $1,619,670.09 |
DisclosureSEC source: 0001437749-20-002975 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,381 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| October 23, 2019 Filed Oct 24, 2019 17:51 UTC |
FORMICA FRANK JDirector
|
Disposition to issuerCommon Stock | 6,500 | $26.19 | $170,235.00 |
DisclosureSEC source: 0001437749-19-020562 · rdgdoc.xml · nonDerivative · entry 1 FORMICA FRANK J · CIK 0001263825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,000 Read SEC document |
| October 23, 2019 Filed Oct 24, 2019 17:51 UTC |
FULGONI GIANDirector
|
SaleCommon Stock | 12,000 | $26.45 | $317,400.00 |
DisclosureSEC source: 0001437749-19-020561 · rdgdoc.xml · nonDerivative · entry 1 FULGONI GIAN · CIK 0001254384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,900 Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 19:19 UTC |
Campbell Leslie C.G.Director
|
GrantCommon Stock | 7,500 | $15.98 | $119,850.00 |
DisclosureSEC source: 0001437749-19-014928 · rdgdoc.xml · nonDerivative · entry 1 Campbell Leslie C.G. · CIK 0001686078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Ms. Campbell retains voting rights over all the shares while in escrow. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 19:20 UTC |
SCHWEITZER ROBERT CDirector
|
GrantCommon Stock | 7,500 | $15.98 | $119,850.00 |
DisclosureSEC source: 0001437749-19-014930 · rdgdoc.xml · nonDerivative · entry 1 SCHWEITZER ROBERT C · CIK 0001254385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,834 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Schweitzer retains voting rights over all the shares while in escrow. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 19:20 UTC |
KORN RONALD JDirector
|
GrantCommon Stock | 7,500 | $15.98 | $119,850.00 |
DisclosureSEC source: 0001437749-19-014929 · rdgdoc.xml · nonDerivative · entry 1 KORN RONALD J · CIK 0001249320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,833 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Korn retains voting rights over all the shares while in escrow. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 19:19 UTC |
FULGONI GIANDirector
|
GrantCommon Stock | 7,500 | $15.98 | $119,850.00 |
DisclosureSEC source: 0001437749-19-014927 · rdgdoc.xml · nonDerivative · entry 1 FULGONI GIAN · CIK 0001254384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,900 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Fulgoni retains voting rights over all the shares while in escrow. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 17:16 UTC |
AKDAG MENDERESDirector · CEO & President
|
GrantCommon Stock | 40,000 | $15.98 | $639,200.00 |
DisclosureSEC source: 0001437749-19-014914 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,000 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released over a one year period condition upon continued employment. Mr. Akdag retains voting rights over all the shares while in escrow. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 19:19 UTC |
FORMICA FRANK JDirector
|
GrantCommon Stock | 7,500 | $15.98 | $119,850.00 |
DisclosureSEC source: 0001437749-19-014926 · rdgdoc.xml · nonDerivative · entry 1 FORMICA FRANK J · CIK 0001263825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,500 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Formica retains voting rights over all the shares while in escrow. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 17:17 UTC |
ROSENBLOOM BRUCE SChief Financial Officer
|
GrantCommon Stock | 9,450 | $15.98 | $151,011.00 |
DisclosureSEC source: 0001437749-19-014915 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,884 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Rosenbloom retains voting rights over all the shares while in escrow. Read SEC document |
| September 13, 2018 Filed Sep 14, 2018 19:59 UTC |
SCHWEITZER ROBERT CDirector
|
SaleCommon Stock | 7,500 | $37.00 | $277,500.00 |
DisclosureSEC source: 0001437749-18-017051 · rdgdoc.xml · nonDerivative · entry 1 SCHWEITZER ROBERT C · CIK 0001254385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,334 Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 19:31 UTC |
SCHWEITZER ROBERT CDirector
|
GrantCommon Stock | 7,500 | $35.43 | $265,725.00 |
DisclosureSEC source: 0001437749-18-014093 · rdgdoc.xml · nonDerivative · entry 1 SCHWEITZER ROBERT C · CIK 0001254385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,834 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Schweitzer retains voting rights over all the shares while in escrow. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 19:30 UTC |
KORN RONALD JDirector
|
GrantCommon Stock | 7,500 | $35.43 | $265,725.00 |
DisclosureSEC source: 0001437749-18-014092 · rdgdoc.xml · nonDerivative · entry 1 KORN RONALD J · CIK 0001249320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,333 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Korn retains voting rights over all the shares while in escrow. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 19:30 UTC |
FORMICA FRANK JDirector
|
GrantCommon Stock | 7,500 | $35.43 | $265,725.00 |
DisclosureSEC source: 0001437749-18-014090 · rdgdoc.xml · nonDerivative · entry 1 FORMICA FRANK J · CIK 0001263825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Formica retains voting rights over all the shares while in escrow. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 19:30 UTC |
FULGONI GIANDirector
|
GrantCommon Stock | 7,500 | $35.43 | $265,725.00 |
DisclosureSEC source: 0001437749-18-014091 · rdgdoc.xml · nonDerivative · entry 1 FULGONI GIAN · CIK 0001254384 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,400 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2015 Outside Director Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Fulgoni retains voting rights over all the shares while in escrow. Read SEC document |
| July 27, 2018 Filed Jul 31, 2018 19:17 UTC |
ROSENBLOOM BRUCE SChief Financial Officer
|
GrantCommon Stock | 10,500 | $35.43 | $372,015.00 |
DisclosureSEC source: 0001437749-18-014084 · rdgdoc.xml · nonDerivative · entry 1 ROSENBLOOM BRUCE S · CIK 0001251340 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,434 F1 · shares: Issued pursuant to the terms and conditions of the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, and held in escrow to be released ratable over a three year period condition upon continued employment. Mr. Rosenbloom retains voting rights over all the shares while in escrow. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 15:17 UTC |
FORMICA FRANK JDirector
|
SaleCommon Stock | 5,000 | $41.78 | $208,900.00 |
DisclosureSEC source: 0001437749-18-011783 · rdgdoc.xml · nonDerivative · entry 1 FORMICA FRANK J · CIK 0001263825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,500 Read SEC document |
| January 29, 2018 Filed Jan 30, 2018 14:26 UTC |
KORN RONALD JDirector
|
SaleCommon Stock | 5,000 | $48.38 | $241,900.00 |
DisclosureSEC source: 0001437749-18-001321 · rdgdoc.xml · nonDerivative · entry 1 KORN RONALD J · CIK 0001249320 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,833 Read SEC document |
| January 22, 2018 Filed Jan 24, 2018 14:41 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 10,000 | $57.00 | $570,000.00 |
DisclosureSEC source: 0001437749-18-001023 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 11:01 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 10,000 | $53.00 | $530,000.00 |
DisclosureSEC source: 0001437749-18-000597 · rdgdoc.xml · nonDerivative · entry 2 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
| January 11, 2018 Filed Jan 16, 2018 11:01 UTC |
AKDAG MENDERESDirector · CEO & President
|
SaleCommon Stock | 30,000 | $51.00 | $1,530,000.00 |
DisclosureSEC source: 0001437749-18-000597 · rdgdoc.xml · nonDerivative · entry 1 AKDAG MENDERES · CIK 0001254383 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,000 F1 · shares: The reported transactions are pursuant to a pre-arranged structured sales plan that is in accordance with both the Securities and Exchange Commission's Rule 10b5-1 and the PetMed Express, Inc. insider trading policy. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.